MEDI7352

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Painful Diabetic NeuropathyPainful Osteoarthritis of the Knee

Phase 1

Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers

CompletedNCT04770428

AstraZenecaPainful Osteoarthritis of the Knee

Start: 2021-04-20End: 2021-12-02Updated: 2021-12-15

Phase 2

Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy

TerminatedNCT03755934

AstraZenecaPainful Diabetic Neuropathy

Start: 2018-11-19End: 2023-06-29Updated: 2024-09-19

A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee

CompletedNCT04675034

AstraZenecaPainful Osteoarthritis of the Knee

Start: 2020-12-02End: 2023-08-16Updated: 2025-02-10